IPO审1过1

Core Viewpoint - Suzhou Fengbei Biotechnology Co., Ltd. has received approval for its IPO application from the Shanghai Stock Exchange, indicating a positive outlook for the company's growth in the waste oil resource utilization sector [2]. Group 1: Company Overview - Fengbei Biotechnology is a high-tech enterprise focused on the comprehensive utilization of waste resources, primarily producing resource-based products from waste oil [4]. - The company's main business includes waste oil resource utilization, with secondary operations in oil chemical products [4]. - Key products include bio-based materials (such as pesticide and fertilizer additives) and biofuels (primarily biodiesel) [4]. Group 2: Financial Performance - The company's revenue for the reporting period was 1,708.69 million yuan, 1,727.78 million yuan, and 1,948.02 million yuan, showing a growth trend [6]. - The net profit attributable to the parent company was 135.92 million yuan, 123.04 million yuan, and 115.32 million yuan during the same periods, indicating a decline in profitability [6]. Group 3: Shareholding Structure - The controlling shareholder and actual controller of Fengbei Biotechnology is Pingyuan, who directly holds 59.78% of the shares and indirectly controls an additional 25.62% through other entities [5]. - Pingyuan holds a total of 85.40% of the company's shares and serves as the chairman [5]. Group 4: Key Questions from the Listing Committee - The listing committee raised questions regarding the company's customer and product structure adjustments for 2024, as well as the reasons for the decrease in sales and management expenses compared to 2023 [7]. - Concerns were also expressed about the sustainability of revenue from biofuels and the growth potential of industrial-grade mixed oil, along with the overall stability of the company's operating performance [7].